Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 378 participants.
Also called NCT05691959
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 378 participants
- Sponsor
- Ascension Health
- Registry
-
NCT05691959
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05691959. Randomized; quadruple masking; primary purpose treatment. Start 2023-01-26 (anticipated); primary completion 2025-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response
- Condition
- Atrial Fibrillation With Rapid Ventricular Response
- Condition
- Hypotension
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Calcium
- Lead sponsor
- Ascension Health
Record details
- Record id
cardio:ct-nct05691959- Content hash
1e9e57923217447243e112c58e8e316dc299fd4611b66d02c176ba266eacf77d